Table 7 The sensitivity analysis at 25% sharing rate for cumulative annual cost saving, cost - effectiveness and cost – benefit of SIF in Montreal
Variables | Annual cost of operation | Sharing rate | # of HIV averted | # of HCV averted | HIV cost saved | HCV cost saved | Cost-effectiveness ratio HCV | Cost-effectiveness ratio HIV | Cost-benefit ratio HCV | Cost-benefit ratio HIV |
|---|---|---|---|---|---|---|---|---|---|---|
Post SIF | $2,182,800 | 25% | 10 | 64 | -$77,250 | $66,352 | $34,106 | $218,280 | 1.03 | 1 |
Two SIF | $4,365,600 | 20% | 19 | 119 | -$365,055 | -$183,583 | $36,686 | $229,768 | 0.96 | 0.92 |
Three SIF | $6,548,400 | 15% | 23 | 142 | -$1,705,635 | -$1,558,094 | $46,156 | $284,713 | 0.76 | 0.74 |
Four SIF | $8,731,200 | 13% | 27 | 166 | -$3,046,215 | -$2,897,462 | $52,598 | $323,377 | 0.67 | 0.65 |
Five SIF | $10,914,000 | 11% | 31 | 190 | -$4,386,795 | -$4,236,830 | $57,442 | $352,065 | 0.61 | 0.6 |
Six SIF | $13,096,800 | 9% | 35 | 213 | -$5,727,375 | -$5,611,341 | $61,487 | $374,194 | 0.57 | 0.56 |
Seven SIF | $15,279,600 | 7% | 39 | 237 | -$7,067,955 | -$6,950,709 | $71,735 | $436,560 | 0.55 | 0.54 |
Average | $8,731,200 | 14% | 26 | 154 | -$3,256,770 | -$3,319,178 | $56,696 | $335,815 | 0.62 | 0.63 |